Description
Human Ovarian Mucinous Carcinoma Tumor Cells are derived from human ovarian mucinous carcinoma tissues, providing a robust platform for studying ovarian cancer biology, progression, and therapeutic strategies. These cells exhibit key pathological features, including mucin secretion, aggressive growth behavior, resistance to apoptosis, and chemotherapeutic resistance mechanisms, closely resembling the clinical manifestations of ovarian mucinous carcinoma. Frequently employed to investigate oncogenic pathways, such as EGFR signaling, mucin-related glycoproteins expression, and epithelial-mesenchymal transition (EMT), these cells facilitate discovery of targeted therapeutics and biomarkers. They serve as valuable models for drug screening, mechanistic research, and personalized oncology.
| Species |
Human
|
| Cat.No |
ABC-TC153W
|
| Quality Control |
All cells test negative for mycoplasma, bacteria, yeast, and fungi.
|
| Product Category |
Primary Cells |
| Size/Quantity |
1 vial
|
| Cell Type |
Tumor Cell
|
| Growth Mode |
Adherent
|
| Shipping Info |
Dry Ice
|
| Growth Conditions |
37 °C, 5% CO2
|
| Source Organ |
Ovarian mucinous carcinoma tissues
|
| Disease |
Ovarian Mucinous Carcinoma
|
| Biosafety Level |
1
|
| Storage |
Liquid Nitrogen
|
| Product Type |
Ovarian Mucinous Carcinoma Tumor Cells
|
